BridgeMD
Tests treatment safety and results for Osteoarthritis, Hip
Official title 6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis
ClinicalTrials.gov ID: NCT05829733
What this study is testing
- What it's testing
- Multicenter, independent study of Synolis VA 80/160 over a period of 6 months
- Time commitment: about 6 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient over 18 years of age,
- Patient with osteoarthritis of the hip. The diagnosis is based on the following criteria:
- Treated hip pain: Oxford score ≥ 21/60,
- Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit),
- Symptoms related to osteoarthritis of the hip for at least 2 months,
You likely can't join if
- Pregnancy,
- Participation in another clinical trial,
- Skin lesion near the injection site,
- Recent or old infection of the affected joint,
- Patient with a programmed arthroplasty,
- Patient with a pathology that makes decision-making impossible,
See the full eligibility criteria
- Patient over 18 years of age,
- Patient with osteoarthritis of the hip. The diagnosis is based on the following criteria:
- Treated hip pain: Oxford score ≥ 21/60,
- Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit),
- Symptoms related to osteoarthritis of the hip for at least 2 months,
- Failure of treatments (i.e., inadequate or ineffective response to analgesics and/or NSAIDs or intolerance to NSAIDs or low-grade opioids (leaving an OXFORD score ≥ 21/60),
- Informed consent form signed by the patient,
- The patient has never had a visco supplement injection or corticosteroid injection in the hip to be treated (or more than 6 months old).
- Pregnancy,
- Participation in another clinical trial,
- Skin lesion near the injection site,
- Recent or old infection of the affected joint,
- Patient with a programmed arthroplasty,
- Patient with a pathology that makes decision-making impossible,
- The patient must not have undergone non-prosthetic hip-conserving surgery such as osteotomy or arthroscopy less than 12 months old.
The study team makes the final eligibility decision.
Where it's taking place
- Belfort, France
- Dunkirk, France
- Lille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Belfort, France; Dunkirk, France; Lille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.